Blumax Pharma And Nutraceuticals Private Limited - Company Profile

It is a business services private limited company based in Pondicherry, Pondicherry, India, established in 2024.
2024 Pondicherry, Pondicherry, India Active
Last Updated:
Access Report
About Blumax Pharma And Nutraceuticals Private Limited

Blumax Pharma And Nutraceuticals Private Limited, a active private limited company, was established on 27 August 2024 in Pondicherry, Pondicherry, India. it holds CIN: U46596PY2024PTC009283. Registered under ROC Roc Pondicherry. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Anandakumar Ponnala (Director), Jackson Benny Jacob (Director), Prabath Kumar Ponnala (Director). It is based at Door No 6-2-015, Opp Park, Kurasampeta, Pondicherry, Pondicherry, 533464.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U46596PY2024PTC009283

  • Registration Number

    009283

  • Incorporation Date

    27 August 2024

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Pondicherry

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 1 Year 6 Months
Company report

Blumax Pharma And Nutraceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Blumax Pharma And Nutraceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Blumax Pharma And Nutraceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Anandakumar Ponnala Director 27 Aug 2024 Current
Jackson Benny Jacob Director 27 Aug 2024 Current
Prabath Kumar Ponnala Director 27 Aug 2024 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Blumax Pharma And Nutraceuticals.

Enhance accessibility to Blumax Pharma And Nutraceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Blumax Pharma And Nutraceuticals revenue growth over time
Blumax Pharma And Nutraceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Blumax Pharma And Nutraceuticals?

Unlock access to Blumax Pharma And Nutraceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Blumax Pharma And Nutraceuticals?

Unlock and access historical data on people associated with Blumax Pharma And Nutraceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Blumax Pharma And Nutraceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Blumax Pharma And Nutraceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Blumax Pharma And Nutraceuticals
Recent Activity within the Organization
  • Director Appointment

    Progress on Anandakumar Ponnala was appointed as a Director was appointed as a Director on 27 Aug 2024 & has been associated with this company since 1 year 6 months . was documented.

  • Director Appointment

    The activity Jackson Benny Jacob was appointed as a Director was appointed as a Director on 27 Aug 2024 & has been associated with this company since 1 year 6 months . was completed.

  • Director Appointment

    The activity Prabath Kumar Ponnala was appointed as a Director was appointed as a Director on 27 Aug 2024 & has been associated with this company since 1 year 6 months . was completed.

  • Company Incorporation

    Progress on Blumax Pharma And Nutraceuticals Private Limited was registered on 27 Aug 2024 with Roc Pondicherry & aged 1 year 6 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Blumax Pharma And Nutraceuticals Private Limited?

The CIN of Blumax Pharma And Nutraceuticals Private Limited is U46596PY2024PTC009283.

Where is Blumax Pharma And Nutraceuticals Private Limited headquartered?

Blumax Pharma And Nutraceuticals Private Limited is headquartered at Door No 6-2-015, Opp Park, Kurasampeta, Pondicherry, Pondicherry, 533464.

When was Blumax Pharma And Nutraceuticals Private Limited incorporated?

Blumax Pharma And Nutraceuticals Private Limited was incorporated on 27 August 2024.

Who are the current directors of Blumax Pharma And Nutraceuticals Private Limited?

The current directors of Blumax Pharma And Nutraceuticals Private Limited are

Is Blumax Pharma And Nutraceuticals Private Limited a listed company?

Blumax Pharma And Nutraceuticals Private Limited is unlisted.

What is the capital structure of Blumax Pharma And Nutraceuticals Private Limited?

The authorized capital of Blumax Pharma And Nutraceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available